<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Evidence shows that <z:mp ids='MP_0002055'>diabetes</z:mp> increases the risk of developing <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) </plain></SENT>
<SENT sid="1" pm="."><plain>Many efforts have been done to elucidate the mechanisms linking <z:mp ids='MP_0002055'>diabetes</z:mp> and AD </plain></SENT>
<SENT sid="2" pm="."><plain>To demonstrate that mitochondria may represent a functional link between both pathologies, we compared the effects of AD and <z:chebi fb="27" ids="17992">sucrose</z:chebi>-induced metabolic alterations on mouse brain <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> bioenergetics and oxidative status </plain></SENT>
<SENT sid="3" pm="."><plain>For this purpose, brain mitochondria were isolated from <z:mp ids='MP_0002169'>wild-type</z:mp> (WT), triple transgenic AD (3xTg-AD), and WT mice fed 20% <z:chebi fb="27" ids="17992">sucrose</z:chebi>-sweetened water for 7 months </plain></SENT>
<SENT sid="4" pm="."><plain>Polarography, spectrophotometry, fluorimetry, high-performance liquid chromatography, and electron microscopy were used to evaluate <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function, oxidative status, and ultrastructure </plain></SENT>
<SENT sid="5" pm="."><plain>Western blotting was performed to determine the AD pathogenic protein levels </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="27" ids="17992">Sucrose</z:chebi> intake caused metabolic alterations like those found in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Mitochondria from 3xTg-AD and <z:chebi fb="27" ids="17992">sucrose</z:chebi>-treated WT mice presented a similar impairment of the respiratory chain and phosphorylation system, decreased capacity to accumulate calcium, ultrastructural abnormalities, and oxidative imbalance </plain></SENT>
<SENT sid="8" pm="."><plain>Interestingly, <z:chebi fb="27" ids="17992">sucrose</z:chebi>-treated WT mice presented a significant increase in amyloid Î² protein levels, a hallmark of AD </plain></SENT>
<SENT sid="9" pm="."><plain>These results show that in mice, the metabolic alterations associated to <z:mp ids='MP_0002055'>diabetes</z:mp> contribute to the development of AD-like pathologic features </plain></SENT>
</text></document>